INHSU Africa 2020
INHSU Africa 2020

Program

The committee are excited to announce the program overview is now available. This will continue to be updated as more details are confirmed, please note this is subject to change without notice.

Please note there is no Abstract Submission for this conference.

The interactive program is available via the below button, click on the sessions to view the presentations and speakers.

Monday 17 February 2020 – Advocacy Meeting

Pre-Meeting 
8.30 -
9.00
Registrations
9.00 -
9.30
Advocacy Meeting Welcoming Remarks, Introductions & Workshop Objectives
Happy Assan, African Network of People Who Use Drugs
Angela McBride, South African Network of People Who Use Drugs
9.30 -
10.15
Setting the Scene: Overview of country and regional contexts, and advocacy priorities
Facilitators: Chris Abuor, Vocal, Kenya and Karim Diop, Government of Senegal

Panellists (TBC):
Fumni Lesi, WHO, Congo
Ahmed Said KenPUD, Kenya
Moustapha Mbodj, SEV Association, Senegal
Wangari Kimemia, Medecins du Monde, Kenya
10.15 -
11.00
Hepatitis Basics & What Advocates Need to Know
Tracy Swan, Consultant, USA
Angela McBride, SANPUD, South Africa
Connie van Staden, SANPUD, South Africa
Luckyboy Mkhondwane, TAC, South Africa
11.00-
11.30
Coffee break
11.30 -
13.00
“Speed Geek” Exchange & Lessons Sharing
Harm reduction and hepatitis advocacy and services in prisons (Taha Brahni - ALCS)

Needle and syringe services (Happiness Madunda, Mikikute)

Harm reduction and hepatitis services for women (Fatma Jeneby, MEWA, Kenya)

Integration, decentralisation and implication (Belarmino Langa, Unidos, Mozambique)

Core advocacy messages/lessons around viral hepatitis and harm reduction (Kunal Naik, Pils, Mauritius)

Community involvement in policy development (Happy Assan, TanPUD)
13.00 -
14.00
Lunch
14.00 -
15.30
Visioning Exercise & Campaign Strategizing
Annette Gaudino, TAG, USA and colleagues
Rebecca Vanserotti, INHSU, Australia
Luckyboy Mkhondwane, TAC, South Africa
15.30 -
16.00
Action Plans & Follow Up Mechanisms
Kunal Naik, PILS, Mauritius
Luckyboy, TAC, South Africa
16.00 -
16.30
Closing reflections & group photo
Shaun Shelly, TB HIV Care and South African Network of People Who Use Drugs, South Africa
16.30 -
17.00
Advocacy bazaar
Supporting and participating organisations

Tuesday 18 February 2020 – INHSU & UNITE Joint Action Policy Day

Pre-MeetingINHSU & UNITE Joint Action Policy Day 2020: Policy Actions to Acelerate Hep C and
HIV elimination among people who use drugs in Africa
7.45 -
8.15
Registration (Outside Central 1 and 2, Conference level, Double Tree by Hilton, Woodstock)
8.15 -
8.30
Briefing for site visits (Julie MacDonnell, SA Drug Policy Week, South Africa) (Central 1 and 2 Double Tree, Conference level, Double Tree by Hilton, Woodstock)
08.30 –
12.00
Site visits
12.00
- 13.00
Lunch and registration
13.00 –
13.05
Welcome
Dr Gareth Lowndes (TB HIV Care COO, South Africa)
13.05 –
13.10
Overview of INHSU
Prof Jason Grebely (INHSU President)
13.10 –
13.20
Harm reduction, health, rights and policy
Dr Nomafrench Mbombo (Western Cape Minister of Health)
13.20 –
14.30
Drug policy, harm reduction and human rights to eliminate Hep C and other IDs in Africa
13.20 -
13.25
Chairs: Ms Coceka Nogoduka (South African National AIDS Council, South Africa) and Helgar Musyoki (National AIDS and STIs Control Programme, Kenya)
13.25 -
13.35
An overview on drug policy, human rights and infectious diseases
Dr Frank Lule, WHO
13.35 -
13.45
Drug policy in reform in Africa
Maria-Goretti Loglo, IDPC
13.45 -
13.55
Integrated community-based interventions: a gender based approach
Happy Assan, African Network of People Who Use Drugs
13.55 -
14.05
HIV and Hepatitis C elimination as political will
Ricardo Baptista Leite, UNITE
14.05 -
14.30
Questions and answers
14.30
15.00
Coffee Break and Networking
15.00 –
16.00
Interactive discussions and comparative analysis of harm reduction and drug policy reform
Guest: Dr Jessica Seleme (Ministry of Health, Mozambique)

Speakers:
• Political leadership for harm reduction and policy, UNITE (Portugal) and MP (Tanzania)

• Financing, Sean Casey Clinton Health Access Initiative (U.S.A)

• Decriminalisation, legalisastion and legal regulation, Shaun Shelly, SANPUD (South Africa)

• Human rights and gender to advance drug policy, MEWA (Kenya), CUT (Mauritius)

• The West African Model Drug Law, Maria-Goretti Loglo, IDPC (Ghana)

• Embedding science & cost-effectiveness in policy, Prof. Vickerman, Bristol University (UK)
16.00 –
16.50
Drug policy action planning
Different country break-outs
Brainstorming and priority setting around drug policy reform
16.50 –
17:00
Site visit reflections
17.00 –
17.10
Advocacy day reflections and priorities
17.10 –
17.20
Policy day key issues
17.20 –
17.30
Closing

Wednesday 19 February 2020 – Conference Day 1

Day 1 
7:30Registration
08.30 -
10.45
Opening Ceremony and Session A: Viral hepatitis in context

08.30 -
08.45
Setting the Scene - Local welcome
Andrew Scheibe, TB HIV Care and University of Pretoria, South Africa
08.45 -
09.00
The International Network on Hepatitis in Substance Users
Jason Grebely, INHSU President, Australia
09.00 -
09.15
Welcome to the Conference
Zukiswa Pinini, National Department of Health, South Africa
09.15 -
09.30
Viral hepatitis elimination targets, policy and gaps in Africa
Olufunmilayo Lesi, WHO, Republic of Congo
09.30 -
09.45
Priority health and social issues for people who use drugs
Happy Assan, Tanzania, African Network of People Who Use Drugs
09.45 -
10.00
Strategies to enhance integrated prevention and care for people who use drugs: Lessons learned from HIV
Linda-Gail Bekker, Desmond Tutu HIV Foundation, South Africa
10:00 -
10:30
Questions & Discussion
10.30 -
11.00
Tea Break
11.00 -
11.30
Session B: Connecting with Care
11.00 -
11.10
Screening of Connecting with Care video (South Africa)
11.10 -
11.30
Questions & Discussion
11.30 -
13.15
Session C: Health interventions for people who use drugs
11.30 -
11.45
Harm reduction and health
Wangari Kimemia, Medecins du Monde, Kenya
11.45 -
12.00
Needle and syringe services
Happiness Madunda, Mukikite , Tanzania 
12.00 -
12.30
Opioid substitution therapy (with translation)
Moustapha Mbodj, SEV Association, Senegal
12.30 -
12.45
Community-led responses for women who use drugs
Fatma Jeneby, MEWA, Kenya
12.45 -
13.15
Questions & Discussion
13.15 -
14.15
Lunch
14.15 -
15.45
Session D: HCV testing and diagnosis
14.15 -
14.30
Innovations in the viral hepatitis response
Philippe Duneton, Unitaid, Switzerland
14.30 -
14.45
Hepatitis C: virology, transmission and clinical presentations
Neliswa Gogela, University of Cape Town/ Groote Schuur Hospital, South Africa
14.45 -
15.00
Diagnostics and point-of-care technologies to enhance HCV testing and treatment
Karine Lacombe, ANRS, France
15.00 -
15.15
Strategies to enhance HCV testing and linkage to care for HCV infection
Jason Grebely, The Kirby Institute, UNSW Sydney, Australia
15.15 -
15.45
Questions & Discussion
15.45 -
16.15
Tea Break
16.15 -
16.30
Direct acting antivirals: a revolution in cure
Mark Sonderup, University of Cape Town/ Groote Schuur Hospital, South Africa
16.30 -
16.45
Integrated HIV, TB and viral hepatitis services for people who use drugs
Wendy Spearman, University of Cape Town/ Groote Schuur Hospital, South Africa
16.45 -
17.00
DAA treatment outcomes and reinfection among people who inject drugs
Greg Dore, The Kirby Institute, UNSW Sydney, Australia
17.00 -
17.30
Questions & Discussion

Thursday 20 February 2020 – Conference Day 2

Day 2 
09.00 -
10.30
Session F: Informing policy and practice
09.00 -
09.15
Mathematical modelling to inform viral hepatitis practice and policy in Africa
Peter Vickerman, University of Bristol, England
09:15 -
09.30
Market dynamics and the hepatitis C response: Facilitating policy decisions to improve affordable, equitable access to treatment in Africa
Sean Regan, Clinton Health Access Initiative, USA
09.30 -
09.45

Gathering evidence and monitoring responses and surveillance
Niklas Luhmann, WHO, Switzerland
09.45 -
10.15
Questions & Discussion
10.15 -
10.45
Tea Break
10.45 -
12.30
Session G: Regional and national responses towards hepatitis C and health for people who use drugs
10:45 -
11.00
Supporting plans to address hepatitis and health for people who use drugs through strong government leadership
Oscar Mukasa, Member of Parliament, Tanzania; UNITE Member; Member and Chairperson of parliamentary committee for HIV affairs, TB and Narcotics, Tanzania & Amish Laxmidas, UNITE, Portugal
11:00 -
11:15
Success towards progress of elimination of hepatitis C in Egypt: Lessons learned to inform other settings in Africa
Manal El-Sayed, Ain Shams University, Egypt
11:15 -
11:30
Regional network of HR and OST in West Africa
Karim Diop, Government of Senegal
11:30 -
11:45
South Africa: Experiences of Implementing a National Hepatitis Action Plan that includes people who use drugs
Kgomotso Vilakazi Nhlapo, National Department of Health, South Africa
11:45 -
12:00
Enhancing the HCV response for people who use drugs in Kenya
Helgar Musyoki, National AIDS and STI Control Programme, Kenya
12:00 -
12:30
Questions & Discussion
12.30 -
13:30
Lunch
13.30 -
15.00
Session H: Programatic examples of successful integration of services to address hepatitis C, HIV and the wellbeing of people who use drugs
13.30 -
13:40
Addressing viral hepattis among people who use drugs through microplanning in Tanzania: MdM Temeke Model
Lina Saguti, MdM, Tanzania
13:40 -
13:50
MSF (Mozambique)
Gabriel Wishik, MSF, Mozambique and Jessica Seleme, Ministry of Health Mozambique
13:50 -
14:00
PILS (Mauritius)
Kunal Naik, PILS, Mauritius
14:00 -
14:10
ALCS (Morocco)
Taha Brahni, ALCS, Morocco
14:10 -
14:20
COSUP (South Africa)
Matilda Mohale, Univerity of Pretoria, South Africa
14:20 -
15:00
Questions & Discussion
15.00 -
15.30
Tea Break
15.30 -
17.00
Session I: Key considerations for hepatitis elimination and the health of people who use drugs
15:30 -
15:45
HCV and harm reduction services in prisons
Matthew Akiyama, INHSU Prisons SIG
15:45 -
16:00
Decriminalization and drug policy reform in Africa
Maria-Goretti Loglo, Internatianal Drug Policy Consortium, Ghana
16:00 -
16:15
Harm reduction, law enforcement and an environment for addressing hepatitis C, drug user health, and human rights
Dr. Casian Nyandindi, Director, Drug Control and Enforcement Agency, Tanzania
16:15 -
16:30
An advocacy agenda to eliminate viral hepatitis C and improve the health of people who use drugs in Africa
Shaun Shelly, TB HIV Care and South African Network of People Who Use Drugs, South Africa
16:30 -
16:45
Substance use, social determinants of health and gender
Henrietta Bogopane-Zulu, Deputy Minister, South African Department of Social Development, South Africa
16:45 -
17:00
Q&A and Closing